Share this page!

Enter URL or ID to Unroll

You can paste full URL like: https://x.com/threadreaderapp/status/1644127596119195649
or just the ID like: 1644127596119195649

How to get URL link on X (Twitter) App

  1. On the Twitter thread, click on or icon on the bottom
  2. Click again on or Share Via icon
  3. Click on Copy Link to Tweet
  4. Paste it above and click "Unroll Thread"!
  5. More info at Twitter Help
Riya Sam, MD Profile picture
Riya Sam, MD
@RiyaSam12
#ACCFIT @UCNSCards • Former Chief Resident • ABIM certified • ACC Mentee • Board game geek • Bibliophile📚 • Malayali 🇮🇳 from 🇴🇲 • Jer 29:11 ✝️
Nov 15, 2023 • 40 tweets • 5 min read
#AHA23 LBCTs one liners:

1. SELECT: Among patients w/ overweight or obesity + established CVD w/o DM once-weekly SQ SEMAGLUTIDE was associated with a decreased risk of MACE comprised of CV death, nonfatal MI, and stroke compared with placebo 2.DAPA-MI: Among patients with acute MI w/o a hx of DM or c/c HF, DAPAGLIFLOZIN has better cardiometabolic outcomes compared with placebo, with no difference in CV outcomes.
Aug 28, 2023 • 26 tweets • 4 min read
#ESCCongress #ESC2023 LBCTs one-liners:

1. STEP HFpEF: Semaglutide improves HF related symptoms & physical function and greater weight loss compared to placebo in pts w/ HFpEF & obesity 2. COP-AF: Colchine doesn’t significantly reduce preoperative AF/ myocardial injury after non cardiac surgery(MINS) in pts undergoing major non cardiac surgery
Mar 7, 2023 • 35 tweets • 9 min read
#ACC23 #WCCardio LBCT one-liners:

1. CLEAR Outcomes: Bempedoic acid improves long-term CV outcomes and effectively reduces LDL-C compared with placebo among patients with either established ASCVD or those who have a high risk and w/ intolerance to statin therapy 2. TRILUMINATE Pivotal: Tricuspid TEER was safe for patients with severe TR, reduced the severity and was associated w/ an improvement in QOL

3. HALO: Baxdrostat at the doses studied did not significantly reduce SBP/DBP compared with placebo among patients with uncontrolled HTN
Nov 7, 2022 • 27 tweets • 7 min read
#AHA22 LBCTs one liners:

1. TRANSFORM-HF: Torsemide was not superior to furosemide in improving survival among patients treated for decompensated HF.

2. DCP: No differences in cardiovascular outcomes between chlorthalidone and HCTZ among elderly veterans with HTN. 3. PROMINENT: Pemafibrate did not improve cardiovascular outcomes among patients with diabetes and hypertriglyceridemia.

4. IRONMAN: Iron (ferric derisomaltose) infusion is not superior to usual care among patients with HF and iron deficiency.
Apr 5, 2022 • 13 tweets • 5 min read
#ACC22 LBTs/ Featured Research one liners:

1. VALOR HCM: MAVACAMTEN at 16 weeks in symptomatic HCM decreased the need of SRT

2. Sodium HF: in HF outpatients low-Na diet of 1500 mg/day was not associated with a reduction in CV events but moderate benefit on QoL by KCCQ 3. CHAP: In pregnant women with mild chronic HTN, antihypertensives targeted to a BP <140/90 reduced the incidence of adverse pregnancy outcomes

4. POISE 3: In patients undergoing non cardiac surgery, TRANEXAMIC ACID reduced the risk of bleeding ( non inferiority not met)